FDA Greenlights Generic Rifapentine for Tuberculosis

(MedPage Today) -- The FDA approved the first generic version of rifapentine (Priftin) to treat active pulmonary tuberculosis (TB) in adolescents and adults, as well as latent TB infection in patients as young as 2 years.
The generic rifamycin...